John M. Gill's Insider Trades & SAST Disclosures
John M. Gill's most recent trade in Altimmune Inc was a trade of 34,900 Stock Options (option to buy) done . Disclosure was reported to the exchange on Sept. 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John M. Gill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | John M. Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 34,900 | 34,900 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John Gill M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John M. Gill | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 12 Aug 2022 | 2,714 | 2,771 (0%) | 0% | 15 | 40,710 | Common Stock, par value $0.0001 |
| Altimmune Inc | John M. Gill | Director | Sale of securities on an exchange or to another person at price $ 11.92 per share. | 30 Nov 2020 | 8,425 | 11,199 (0%) | 0% | 11.9 | 100,426 | Common Stock, par value $0.0001 |
| Altimmune Inc | John M. Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,500 | 25,500 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John M. Gill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 19,624 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | John M. Gill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 0 | - | - | Restricted Stock Units ("RSUs") | |
| Altimmune Inc | John M. Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 16,850 | 16,850 | - | - | Restricted Stock Units ("RSUs") |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges